Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Other Accumulated Expenses (2023 - 2025)

Baird Medical Investment Holdings has reported Other Accumulated Expenses over the past 3 years, most recently at $64363.0 for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 98.26% year-over-year to $64363.0; the TTM value through Dec 2025 reached $64363.0, down 98.26%, while the annual FY2025 figure was $64363.0, 98.26% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $64363.0 at Baird Medical Investment Holdings, down from $4.5 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $4.5 million in Q2 2025 and troughed at $64363.0 in Q4 2025.
  • A 3-year average of $3.0 million and a median of $3.7 million in 2023 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: dropped 2.15% in 2024 and later crashed 98.26% in 2025.
  • Year by year, Other Accumulated Expenses stood at $3.8 million in 2023, then decreased by 2.15% to $3.7 million in 2024, then crashed by 98.26% to $64363.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for BDMD at $64363.0 in Q4 2025, $4.5 million in Q2 2025, and $3.7 million in Q4 2024.